EUVIMED · CrossrefZeitschrift
Translational Proteomics
ISSN 2212-9626 · Elsevier BV
Neueste Artikel
WITHDRAWN: Selected abstracts from the Australasian Integrative Medicine Association Conference, Sydney, Australia
Phytotherapy for cardiovascular disease
Is chemotherapy the gold standard?
The therapeutic power of sound
Natural fertility: Naturopathic treatment of sperm DNA fragmentation and reduced egg reserve
The role of heavy metals in autoimmune diseases
The role of metals in cancer
Probiotics for GIT health
Herbal medicine in cancer
Developing the evidence for kinesiology-style manual muscle testing: A series of diagnostic test accuracy studies
Management of female infertility with traditional Chinese herbal medicine: An updated meta-analysis
The art of proteomics translation
The Human Diabetes Proteome Project (HDPP): From network biology to targets for therapies and prevention
Translation of human African trypanosomiasis biomarkers towards field application
Unraveling modulators of platelet reactivity in cardiovascular patients using omics strategies: Towards a network biology paradigm
PanelomiX: A threshold-based algorithm to create panels of biomarkers
Blood microvesicles: From proteomics to physiology
Is clinical proteomics heading towards to “bench to bedside”?
Mass spectrometry based translational neuroinjury proteomics
Advances in mass spectrometry-based technologies to direct personalized medicine in ovarian cancer
Quality requirements for quantitative clinical chemistry proteomics
Molecular mechanisms of increased cerebral vulnerability after repeated mild blast-induced traumatic brain injury
Analysis of plasma from prostate cancer patients links decreased carnosine dipeptidase 1 levels to lymph node metastasis
Profiling of human myotubes reveals an intrinsic proteomic signature associated with type 2 diabetes
Ultrahigh resolution profiles lead to more detailed serum peptidome signatures of pancreatic cancer
Reverse phase protein array based tumor profiling identifies a biomarker signature for risk classification of hormone receptor-positive breast cancer
Chemokines after human ischemic stroke: From neurovascular unit to blood using protein arrays
Microwave and magnetic (M2) proteomics of a mouse model of mild traumatic brain injury
Recent updates on drug abuse analyzed by neuroproteomics studies: Cocaine, Methamphetamine and MDMA
Proteomics as a new paradigm to tackle Parkinson’s disease research challenges
EUVIMED